According to the UnivDatos, the surge in the incidences of rare genetic disorders and associated surge in the demand for targeted therapies will drive the global scenario of the rare genetic disorders treatment and as per their gene therapy market report, the global market was valued at USD 5663.1 million in 2022, growing at a CAGR of 30.1% during the forecast period from 2023 - 2030 to reach...